Insulin Therapy for Type 2 Diabetes ‘May Do More Harm Than Good’

Editor’s note: This article is for educational purposes only and should not be used to start, stop, reduce, or replace prescribed insulin or diabetes medication. Anyone with type 2 diabetes should make treatment changes only with a qualified healthcare professional.

Insulin therapy for type 2 diabetes can be a powerful tool. It can lower dangerously high blood sugar, relieve symptoms, and help prevent long-term complications. But like a power tool in a tiny apartment, it is not always the right instrument for every job. In some peopleespecially older adults, people with a history of low blood sugar, or those already near their individualized A1C goaladding insulin may create more burden than benefit.

The phrase “may do more harm than good” sounds dramatic, and yes, it has the energy of a medical headline wearing tap shoes. But the real message is more careful: insulin is not bad. Poorly matched insulin therapy can be bad. Type 2 diabetes treatment should not chase a single blood sugar number at all costs. It should improve health, reduce complications, protect quality of life, and fit the person who has to live with the plan every single day.

Understanding Insulin Therapy in Type 2 Diabetes

Insulin is a hormone that helps move glucose from the bloodstream into cells, where it can be used for energy. In type 1 diabetes, the body produces little or no insulin, so insulin treatment is essential for survival. Type 2 diabetes is different. Most people with type 2 diabetes still make insulin, especially early in the disease, but their cells do not respond to it well. This is called insulin resistance.

Over time, the pancreas may struggle to keep up. Blood sugar rises. At that point, treatment may include lifestyle changes, metformin, GLP-1 receptor agonists, SGLT2 inhibitors, other oral medicines, or insulin. Some people need insulin temporarily, such as during hospitalization, pregnancy, steroid treatment, infection, or a period of very high blood glucose. Others may need it long term because their pancreas no longer produces enough insulin.

So the question is not, “Is insulin good or bad?” The better question is, “For this specific person, at this specific stage of type 2 diabetes, do the expected benefits outweigh the risks and daily burden?” That is where modern diabetes care becomes more personal and more interesting than a one-size-fits-all prescription pad.

Why Insulin Can Be Helpful

Insulin has one major advantage: it works. When blood sugar is very high, insulin can lower it quickly and reliably. For someone with symptoms such as excessive thirst, frequent urination, unexplained weight loss, blurry vision, or fatigue caused by severe hyperglycemia, insulin can be the treatment that gets the fire under control.

Current diabetes guidance generally supports considering insulin when blood sugar is extremely high, when A1C is very elevated, or when symptoms suggest insulin deficiency. In those cases, delaying insulin may be more dangerous than using it. Long-term high blood sugar can damage blood vessels and nerves, contributing to kidney disease, vision loss, neuropathy, heart disease, stroke, slow-healing wounds, and other serious complications.

Insulin can also be useful when other medications are not tolerated, are contraindicated, are unaffordable, or do not lower glucose enough. For some people, insulin brings stability after months or years of frustrating glucose swings. It can reduce glucose toxicity, improve energy, and sometimes allow other treatments to work better later. In short, insulin is not a punishment and it is not proof that someone “failed” at diabetes. Type 2 diabetes is progressive for many people. Needing more support is biology, not a character flaw.

Where the “More Harm Than Good” Concern Comes From

The concern comes from the balance between benefits and burdens. A well-known analysis of older adults with type 2 diabetes argued that intensive blood sugar lowering may not always add much healthy life expectancy, especially when treatment is difficult, side effects are meaningful, and the person’s risk of future complications is already lower because of age or limited life expectancy.

For example, a younger person with decades ahead may benefit more from tighter glucose control because there is more time to prevent kidney, eye, nerve, and cardiovascular complications. A 45-year-old who lowers A1C meaningfully may gain more long-term benefit than a 78-year-old with several chronic conditions, frequent falls, and an A1C already near target. The older adult may face immediate risks from treatmentlow blood sugar, confusion, dizziness, falls, or emergency room visitswhile the long-term benefit may be small.

This does not mean older adults should ignore diabetes. It means the goal should be sensible, humane, and individualized. A blood sugar target should not become a tiny tyrant sitting on the kitchen counter yelling orders over breakfast.

The Main Risks of Insulin Therapy

1. Hypoglycemia

Hypoglycemia, or low blood sugar, is the most important risk of insulin therapy. For many people with diabetes, blood glucose below 70 mg/dL is considered low, though individual targets may differ. Symptoms can include shakiness, sweating, hunger, fast heartbeat, anxiety, dizziness, headache, blurred vision, weakness, confusion, or irritability. Severe hypoglycemia can cause fainting, seizures, coma, or death.

Low blood sugar is especially concerning in older adults, people with kidney disease, people who live alone, those with memory problems, and anyone with an irregular eating schedule. Insulin must be matched with food, activity, illness, alcohol intake, and changing daily routines. That sounds simple until real life walks in wearing muddy shoes: a missed lunch, an unexpected walk, a stomach bug, a delayed meal, or a double dose by accident.

2. Weight Gain

Insulin can contribute to weight gain. When glucose control improves, the body stops losing excess sugar through urine and begins storing energy more efficiently. That is good if someone was losing unhealthy weight from uncontrolled diabetes. But for many people with type 2 diabetes, additional weight may worsen insulin resistance, increase medication needs, and make diabetes management feel like running on a treadmill that was secretly set to “uphill.”

Weight gain is not guaranteed, and it can often be managed with nutrition planning, physical activity, careful dose adjustment, and sometimes combination therapy with medications that support weight loss. Still, it is a real consideration when deciding whether insulin is the best next step.

3. Treatment Burden

Insulin therapy is not just “take a shot and move on.” It may involve glucose checks, dose timing, injection supplies, refrigeration rules, site rotation, fear of needles, insurance paperwork, pharmacy delays, and constant mental math. Some people handle this beautifully. Others feel overwhelmed, embarrassed, anxious, or exhausted.

That burden matters. A treatment that looks perfect on a chart may fail in real life if it makes the patient miserable or if the regimen is too complicated to follow safely. Diabetes care should improve life, not turn every meal into a courtroom drama.

4. Overtreatment

Overtreatment happens when medication intensity exceeds what a person is likely to benefit from. This is especially relevant in older adults with type 2 diabetes who have an A1C below 7% while taking insulin or medicines that can cause hypoglycemia. In such cases, some guidelines and expert groups support medication review, dose reduction, or deprescribing when appropriate.

The point is not to let glucose run wild. The point is to avoid trading a theoretical long-term benefit for a very real short-term harm, such as falls, confusion, hospital visits, or fear of eating normally.

Why A1C Alone Is Not Enough

A1C is useful because it estimates average blood sugar over about three months. But it is not a complete picture. Two people can have the same A1C and very different lives. One may have steady glucose levels. The other may swing between highs and lows like a roller coaster built by a committee with no safety training.

A1C also does not show how often a person has hypoglycemia, how complicated the treatment plan is, whether they can afford medication, whether they have kidney disease, whether they are frail, or whether they value fewer injections more than a slightly lower number. For this reason, diabetes treatment should consider age, duration of diabetes, cardiovascular and kidney risk, weight goals, hypoglycemia risk, medication cost, lifestyle, preferences, and life expectancy.

When Insulin May Be the Right Choice

Insulin may be appropriate when type 2 diabetes is causing severe hyperglycemia, when A1C is very high, when blood glucose remains uncontrolled despite other therapies, or when symptoms suggest that the body is not producing enough insulin. It may also be needed during acute illness, surgery, hospitalization, pregnancy, or when other medications are unsafe.

Some people feel dramatically better after starting insulin. Their thirst improves, bathroom trips decrease, energy returns, and glucose numbers become less chaotic. For them, insulin is not a villain. It is the firefighter. The problem is using the firefighter to water a houseplant.

When Insulin May Be Too Much

Insulin may be too much when someone has mild elevation in blood sugar, no symptoms, significant hypoglycemia risk, limited expected benefit from tight control, or major difficulty managing injections and monitoring. It may also be worth reassessing when a person has frequent lows, unexplained falls, confusion, weight gain, or an A1C below their individualized target.

In many adults with type 2 diabetes who do not have severe hyperglycemia, newer non-insulin therapies may be preferred before insulin. GLP-1 receptor agonists and dual GIP/GLP-1 medicines can lower blood sugar and support weight loss. SGLT2 inhibitors may provide heart and kidney benefits in selected patients. These medications are not right for everyone, and they have their own side effects, costs, and precautions. But they have changed the treatment conversation. The old ladderlifestyle, metformin, then eventually insulinhas become more flexible.

How to Reduce the Harm if Insulin Is Needed

If insulin is the right choice, the goal is to use it safely. That starts with a clear plan: what type of insulin to take, when to take it, how to adjust doses, what glucose range is too low, what to do during illness, and when to call the healthcare team.

Patients should understand how food, exercise, alcohol, missed meals, and weight changes affect insulin needs. Continuous glucose monitors can help some people see patterns and catch lows earlier, though access and cost vary. Rotating injection sites can reduce skin changes that interfere with absorption. Keeping fast-acting carbohydrates nearby can help treat mild lows. People at risk for severe hypoglycemia may need a glucagon prescription and should teach family or coworkers how to use it.

Most importantly, insulin doses should not be frozen in time. Diabetes changes. Weight changes. Kidney function changes. Appetite changes. Activity changes. A safe insulin plan should be reviewed regularly, especially after starting or increasing medications that reduce appetite or weight, such as GLP-1-based therapies.

Questions Patients Should Ask Before Starting Insulin

Before beginning insulin therapy for type 2 diabetes, patients can ask practical questions: Why do I need insulin now? Is it temporary or likely long term? What A1C or glucose goal is realistic for me? What are my risks for hypoglycemia? Could another medication be tried first? How will insulin affect my weight? How often do I need to check glucose? What should I do if I miss a meal? What should I do if I am sick? How will I afford supplies?

These questions are not being difficult. They are being responsible. A good diabetes plan should survive contact with real life, including grocery budgets, work schedules, family dinners, travel, stress, and the occasional “I forgot my lunch on the kitchen counter” disaster.

Experiences and Real-Life Lessons: When the Treatment Plan Meets the Kitchen Table

People living with type 2 diabetes often describe insulin therapy as both a relief and a responsibility. One common experience is fear before the first injection. Many imagine a painful, complicated ritual, only to discover that insulin pens are smaller and easier to use than expected. The first shot may feel like a major event; by the tenth, it may feel more like brushing teeth with extra paperwork.

Another common experience is frustration with weight. A person may start insulin, see glucose readings improve, and then notice the scale moving in the wrong direction. That can feel deeply unfair. After all, the numbers on the meter are finally behaving, and the scale decides to act like a rebellious teenager. This is where diabetes education matters. Weight gain after insulin does not mean the person is doing something wrong. It may reflect improved glucose storage, fewer calories lost through urine, more snacking to prevent lows, or insulin doses that need adjustment.

Some patients also describe “hypoglycemia anxiety.” After one scary low, they may begin keeping snacks everywhere: in the car, in the nightstand, in a purse, in a desk drawer, and possibly in places snacks have no legal business being. This anxiety is understandable. Low blood sugar can feel frightening and unpredictable. But fear can lead to overcorrecting with too many carbohydrates, which then causes high blood sugar, more insulin, and another swing downward. The solution is not blame. The solution is pattern review, dose adjustment, education, and sometimes technology such as a continuous glucose monitor.

Older adults and caregivers often face a different challenge: simplicity. A complex insulin regimen may work in theory but fail when vision is poor, hands are shaky, memory is unreliable, or meals are inconsistent. In these cases, a safer plan may involve relaxed glucose targets, fewer injections, caregiver support, or reducing medications that cause lows. The best treatment is not always the most aggressive one. Sometimes the best treatment is the one that keeps a person safe, steady, and able to enjoy breakfast without needing a spreadsheet.

There are also positive stories. Some people begin insulin after months of fatigue, thirst, infections, and high readings. Within weeks, they sleep better, think more clearly, and feel less drained. Others use insulin temporarily during illness or after surgery and later return to non-insulin therapy. Some combine basal insulin with lifestyle changes and other medications, then need less insulin over time. These experiences show why blanket statements are risky. Insulin can be too much for one person, exactly right for another, and temporarily necessary for someone else.

The real-life lesson is simple: insulin therapy should be treated as a flexible medical tool, not a moral verdict. Patients deserve clear explanations, realistic goals, and permission to discuss side effects without feeling judged. Clinicians deserve honest feedback about what is actually happening at home. When both sides talk openly, insulin therapy becomes less about chasing perfect numbers and more about building a plan that protects health without stealing quality of life.

Conclusion

Insulin therapy for type 2 diabetes can save health, reduce dangerous hyperglycemia, and help many people regain control. But it is not automatically the best next step for everyone. The concern that insulin “may do more harm than good” is strongest when treatment is too intensive, too burdensome, or too risky for the patient’s age, health status, and personal goals.

The smartest approach is individualized care. For some, insulin is necessary and beneficial. For others, safer options may exist. For many, the answer changes over time. Diabetes treatment should not worship the A1C number while ignoring the person attached to it. A good plan lowers risk, respects daily life, and keeps the patientnot the lab reportat the center.